Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic
Backlash to Trump's vaccine order on Monday has been swift and sharp, with various public health and medical organizations and independent experts calling it “dangerous,” “ unscientific,” “ false and…
'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
Close to a dozen medical device and civil society organisations, among others, have sought a National Medical Devices Regulatory Authority, with the autonomy of telecom body TRAI or insurance's IRDAI, and regulatory oversight of food authority…
Snapchat ads pharma ad disclaimer links
This audio is auto-generated. Please let us know if you have feedback. Snapchat announced a new ad option for pharma marketers on Tuesday. The addition will let pharma advertisers include product disclosure links in their ads, making it easier for…
Why Revolution Medicines May Be Big Pharma's Next Takeover Target
RVMD has surged 492% over one year on daraxonrasib's landmark pancreatic cancer data showing 13.2 versus 6.7 months median overall survival. MRK ranks as the most likely acquirer, with Keytruda's patent cliff mounting pressure and CEO Robert Davis…
Gujarat pharma firm partners held for illegal sale of codeine cough syrup
4 min read Ahmedabad Make us preferred source on Google The Special Operations Group (SOG) of the Ahmedabad City Police has arrested two partners of Ahmedabad-based wholesale pharmaceuticals company on the charge of selling Codeine-based cough…
Warmington defends lobbying work for Purdue Pharma in campaign video
Democratic gubernatorial candidate Cinde Warmington has taken to social media to defend her past work as a lobbyist for Purdue Pharma, the maker of Oxycontin. The three-minute video, in which Warmington speaks directly to the camera seated on a…
FY2026 EPS Estimates for Innate Pharma Reduced by Analyst
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Equities researchers at HC Wainwright dropped their FY2026 EPS estimates for shares of Innate Pharma in a note issued to investors on Monday, August 10th. HC Wainwright analyst S.
India pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36%
India's pharmaceutical exports rose 6.80 per cent to $8.10 billion in the first quarter of FY27, with vaccine shipments surging 35.68 per cent and bulk drugs and drug intermediates growing 13.84 per cent, according to data released by the…
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB
Handelsbanken Fonder AB lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 557,028 shares of the…
BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price
Innate Pharma (NASDAQ:IPHA - Get Free Report) had its price target hoisted by equities researchers at BTIG Research from $8.00 to $9.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a 'buy' rating on the…
Q3 Earnings Forecast for aTyr Pharma Issued By HC Wainwright
aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Equities research analysts at HC Wainwright raised their Q3 2026 EPS estimates for shares of aTyr Pharma in a report released on Monday, August 10th. HC Wainwright analyst J. Pantginis now expects…
Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Recommendation of 'Buy' by Analysts
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has been assigned a consensus rating of 'Buy' from the five research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation, two have…
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC
Wedge Capital Management L L P NC lowered its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.5% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 770,422…
Tema ETFs LLC Trims Stock Position in BridgeBio Pharma, Inc. $BBIO
Tema ETFs LLC lessened its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 32.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 76,076 shares of the…
Bank of America Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target raised by equities research analysts at Bank of America from $101.00 to $104.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm…
Receive a Daily briefing on Pharma Industry News
Get Started